Looking for a simple way to invest $1,000 for the long term? You can buy these four ETFs now and hold them forever. There's always the middle ground, though. Have you ever thought about setting up ...
Cleveland-Cliffs CEO Lourenco Goncalves is blaming "weakness" for keeping Nippon Steel's massive bid to acquire U.S. Steel alive, complicating his company's own plans for a rival bid as the ...
Nippon Steel’s case against the United States for blocking its acquisition of United States Steel is unlikely to succeed, according to attorneys with expertise in relevant areas ...
Photo: Will Oliver - Pool via CNP/Zuma Press Nippon Steel and U.S. Steel last week filed a lawsuit against President Biden and the Committee on Foreign Investment in the United States (Cfius ...
HARRISBURG, Pa. (AP) — The bid by Japan’s Nippon Steel to buy U.S. Steel may have a new lease on life, even as the potential for a new bid for the storied Pittsburgh steelmaker began to emerge ...
Nippon Steel Corp. said Tuesday it "remains the only partner" for United States Steel Corp., vowing to continue pursuing its purchase despite White House opposition and the emergence of a rival offer ...
This entry contains content that may be considered sensitive to some viewers. The planned event took place between 1 p.m. on January 11th and 1 a.m. on January 12th, 2025. On January 12th, the ...
Lourenco Goncalves, Cleveland-Cliffs’ chairman, president, and CEO. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance ...
A new rival bid for US Steel is emerging as the US extends deadline on Nippon’s bid blocked by Biden
Copyright 2025 The Associated Press. All Rights Reserved. A person walks past a Nippon Steel Corporation sign at the company headquarters Tuesday, Jan. 7, 2025, in ...
Lourenco Goncalves, CEO of Cleveland-Cliffs, called Japan, the home of rival steelmaker Nippon Steel, ”evil” in a press conference on Monday, as the U.S. company prepares a new bid for U.S. Steel.
Regenxbio on Tuesday entered into a strategic partnership with Kyoto-based Nippon Shinyaku to advance novel gene therapies for the rare metabolic disorder mucopolysaccharidosis. Unlike many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback